United Therapeutics Corporation: cash_and_equivalents
| Value | {"amount": 1251500000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2024-03-31) |
| Status | current |
| Entity | United Therapeutics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:44:48.732428+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/782bd05c-0e9f-4e73-ad42-56d11b6b97b9
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001082554-24-000025Retrieved: 2026-08-19T10:44:48.732428+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001082554/cash-and-equivalents/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/782bd05c-0e9f-4e73-ad42-56d11b6b97b9
History
- no predecessors — first report